Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Ceftazidime-Avibactam Against Carbapenemase-Positive Klebsiella Pneumoniae Causing Health Care-Associated Infections

NCT07369518 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT07369518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07369518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Ceftazidime-Avibactam Against Carbapenemase-Positive Klebsiella Pneumoniae Causing Health Care-Associated Infections
Lead sponsor
Sohag University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
December 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic sensitivity testing of different antibiotics according to clsi 25, detection of resistance gene in isolates using conventional pcr, detection of some virulence genes using conventional pcr, effect of ceftazidime-avibactam on carbapenemase-producing klebsiella pneumoniae, isolation of kleb. by culture on macconkey agar